Literature DB >> 10962532

HIV-1 tat induced apoptosis of T-cells is not mediated by TGF-beta.

S A Salzman1, J K Burmester.   

Abstract

Recent reports have demonstrated that the HIV-1 transactivator protein, tat, induces apoptosis in T-lymphocyte cell lines, as well as in peripheral blood mononuclear cells, and stimulates a cascade of events resulting in up-regulation of the potent immunosuppressive cytokine, transforming growth factor-beta (TGF-beta). In this study we evaluated the ability of TGF-beta to mediate tat induced apoptosis in T-lymphocyte cell lines. T-cells treated exogenously with either TGF-beta1 or a combination of tat and pan-specific TGF-beta neutralizing antibodies showed little change in the amount of apoptosis. When treated with pan-specific TGF-beta neutralizing antibodies, Jurkat cells that stably express tat protein (Jurkat-tat ) showed only a modest decrease in apoptosis, while CEM-TART cells (CEM T-cells expressing both HIV-1 tat and rev ) demonstrated little change in the amount of apoptosis. In conclusion, we have demonstrated that TGF-beta does not play a significant role in mediating tat induced T-cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10962532     DOI: 10.1007/bf02780530

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  40 in total

1.  Transcription of the HIV-1 LTR is regulated by the density of DNA CpG methylation.

Authors:  K A Gutekunst; F Kashanchi; J N Brady; D P Bednarik
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-06

2.  Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro.

Authors:  C Dingwall; I Ernberg; M J Gait; S M Green; S Heaphy; J Karn; A D Lowe; M Singh; M A Skinner; R Valerio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

Authors:  J A Kovacs; M Baseler; R J Dewar; S Vogel; R T Davey; J Falloon; M A Polis; R E Walker; R Stevens; N P Salzman; Lane H. Clifford
Journal:  N Engl J Med       Date:  1995-03-02       Impact factor: 91.245

4.  Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-beta 1 mRNA expression and protein synthesis in peripheral blood monocytes.

Authors:  D Gibellini; G Zauli; M C Re; D Milani; G Furlini; E Caramelli; S Capitani; M La Placa
Journal:  Br J Haematol       Date:  1994-10       Impact factor: 6.998

5.  Programmed cell death in AIDS-related HIV and SIV infections.

Authors:  M L Gougeon; S Garcia; J Heeney; R Tschopp; H Lecoeur; D Guetard; V Rame; C Dauguet; L Montagnier
Journal:  AIDS Res Hum Retroviruses       Date:  1993-06       Impact factor: 2.205

6.  Programmed death of T cells in HIV-1 infection.

Authors:  L Meyaard; S A Otto; R R Jonker; M J Mijnster; R P Keet; F Miedema
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

Review 7.  Programmed cell death and AIDS: from hypothesis to experiment.

Authors:  J C Ameisen
Journal:  Immunol Today       Date:  1992-10

Review 8.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

9.  Direct interaction of human TFIID with the HIV-1 transactivator tat.

Authors:  F Kashanchi; G Piras; M F Radonovich; J F Duvall; A Fattaey; C M Chiang; R G Roeder; J N Brady
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

10.  Derivation of a biologically contained replication system for human immunodeficiency virus type 1.

Authors:  H Chen; T J Boyle; M H Malim; B R Cullen; H K Lyerly
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

View more
  1 in total

1.  Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Vivian Wasmuth-Peroud; Mehrnush Kalayeh; Adnan Bashir; Robert Diecidue; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.